Aprea Company
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
Stockholm, Stockholms Lan, Sweden
Founded Date:
2003
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
2
Total Funding:
$5.2M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership